← Back to headlines
Indian Drugmaker Granules to Tighten Oversight After US FDA Warning
Indian drugmaker Granules plans to tighten its oversight processes after receiving a warning from the US FDA, according to an executive.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
